✦ LIBER ✦

Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15–24 months and 4–6 years of age

✍ Scribed by Barry S. Auerbach; Modena E. Wilson; Alan M. Lake; Adamadia Deforest; Mark Steinhoff; Neal A. Halsey; the Acellular Pertussis Vaccine Study team

Book ID: 119151470
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 702 KB
Volume: 10
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(92)90413-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose–Response to a Two-Component Acellul

Dose–Response to a Two-Component Acellular Pertussis Vaccine In Infants and Comparison with Whole-cell Vaccine

✍ Barry S Auerbach; Alan M Lake; Modena E Wilson; Field F Willingham; Jon Shematek 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Responses to primary and a booster dose

Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age

✍ Li-Min Huang; Chin-Yun Lee; Tzou-Yien Lin; Jong-Min Chen; Ping-Ing Lee; Ching-Yi 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Comparison of acellular (B type) and who

Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15-to 24-month-old children

✍ Sandor Feldman; C. Steve Perry; Michael Andrew; Leslie Jones; John E. Moffitt 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Effect of priming with diphtheria and te

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children

✍ Audino Podda; Gianni Bona; Gianpaolo Canciani; Anna Maria Casadei Pistilli; Brun 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Reactogenicity and immunogenicity of red

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccine (dTpa) administered as a booster to 4–6 year-old children primed with four doses of whole-cell pertussis vaccine

✍ Pensri Kosuwon; Boonyarat Warachit; Yanee Hutagalung; Thitiporn Borkird; Pope Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Comparison of an acellular pertussis-com

Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody

✍ Dean A. Blumberg; ChrisAnna M. Mink; James D. Cherry; Keith S. Reisinger; Mark M 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 439 KB